Latest News & Updates

Breaking News

  • 19 hours ago

  • Simantini Singh Deo

Aurigene Pharmaceutical Services Scales New Heights in Bispecific Antibody Development
Breaking News
Merck Expands Respiratory Portfolio With Acquisition Of Verona Pharma And Its COPD Drug Ohtuvayre® (Ensifentrine)

Simantini Singh Deo

Pelthos Therapeutics Launches ZELSUVMI™, Making Molluscum Contagiosum The First Skin Condition With An FDA-Approved At-Home Treatment

Simantini Singh Deo

China NMPA Approves Ascentage Pharma’s Lisaftoclax, A First-In-Class Bcl-2 Inhibitor, For Treating CLL/SLL

Simantini Singh Deo

Alvotech Appoints Linda Jónsdóttir As New Chief Financial Officer To Lead Global Biotech Financial Strategy

Simantini Singh Deo

Other trending news you may like to read

Aurigene Pharmaceutical Services Scales New Heights in Bispecific Antibody Development

Aurigene advances bispecific antibody from lab to patient dosing in just 12 months—marking a breakthrough in biologics innovation.

Simantini Singh Deo

Article

Merck Expands Respiratory Portfolio With Acquisition Of Verona Pharma And Its COPD Drug Ohtuvayre® (Ensifentrine)

Merck acquires Verona Pharma for $10B, expanding its COPD pipeline with novel inhaled drug Ohtuvayre.

Simantini Singh Deo

Article

Pelthos Therapeutics Launches ZELSUVMI™, Making Molluscum Contagiosum The First Skin Condition With An FDA-Approved At-Home Treatment

ZELSUVMI: The first at-home FDA-approved gel for molluscum, now available for adults and kids aged 1+.

Simantini Singh Deo

Article

China NMPA Approves Ascentage Pharma’s Lisaftoclax, A First-In-Class Bcl-2 Inhibitor, For Treating CLL/SLL

China approves lisaftoclax, the country’s first Bcl-2 inhibitor for CLL/SLL, advancing precision cancer care.

Simantini Singh Deo

Article